SCHEMBL6002667

SCHEMBL6002667

[CH2]COC(=O)Nc1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MAPT P10636 4/20 0.51
ALDH1A1 P00352 2/20 0.50
TGM2 P21980 1/20 0.50
GAA P10253 3/20 0.49
FAAH O00519 1/20 0.48
CASP3 P42574 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19138244 0.83 SMN1; SMN2 (0.42) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL2097995 0.81 MAPT (0.70) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL2097279 0.81 MEN1 (0.55) MEN1KMT2ATGM2GAAMAPK1
SCHEMBL482922 0.81 NPC1 (0.59) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL2088749 0.81 EPHX2 (0.58) MEN1KMT2ASMN1; SMN2L3MBTL1TGM2
SCHEMBL5073940 0.81 TGM2 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL2092275 0.80 MEN1 (0.60) MEN1KMT2ASMN1; SMN2MAPTGAA
SCHEMBL19938056 0.79 SMN1; SMN2 (0.67) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL19941030 0.79 MEN1 (0.58) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL3230113 0.79 SMN1; SMN2 (0.59) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed